Medtech trade bodies on PIP breast implants: crisis is a result of criminal action, not inadequacy of regulations
This article was originally published in SRA
Executive Summary
The case of the fraudulent PIP breast implants and its repercussions do not have anything to do with shortfalls in the regulatory system but rather with the criminal actions of the implants' French manufacturer.